Mutual Of America Capital Management LLC Immunity Bio, Inc. Transaction History

Mutual Of America Capital Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 02, 2022	SELL	$5.05 - $7.53 $593,066 - $884,315	-117,439 Closed	0 $0
Q4 2021 Feb 03, 2022	SELL	$5.67 - $10.18 $6,214 - $11,157	-1,096 Reduced 0.92%	117,439 $714,000
Q3 2021 Nov 10, 2021	SELL	$9.17 - $14.24 $15,671 - $24,336	-1,709 Reduced 1.42%	118,535 $1.16 Million
Q2 2021 Aug 06, 2021	SELL	$13.41 - $22.4 $578,990 - $967,142	-43,176 Reduced 26.42%	120,244 $1.72 Million
Q1 2021 May 13, 2021	BUY	$12.83 - $42.25 $2.1 Million - $6.9 Million	163,420 New	163,420 $3.88 Million

202

70M

1.68M

1.31M

Ticker IBRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 400,304,000
Market Cap $1.8B
Description
ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...

Get notified when there are updates to the investment portfolio of Mutual Of America Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Mutual Of America Capital Management LLC with notifications on news.